Research graph
References from Treating resistant hypertension; the overlooked role of combined alpha- + beta-blockade. Local targets link to admitted publications; unresolved targets remain external evidence.
AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2025 · External reference
Sympathetic overactivation in the resistant hypertensive phenotype: a meta-analysis of published studies
10.1161/hypertensionaha.125.24749 · 2025 · External reference
Pharmacokinetics and pharmacodynamic studies of labetalol in hypertensive subjects
1979 · External reference
Clinical pharmacokinetics and pharmacodynamics of carvedilol
10.2165/00003088-199426050-00002 · 1994 · External reference
Beta-adrenergic blockers in systemic hypertension: pharmacokinetic considerations related to the current guidelines
10.2165/00003088-200241070-00004 · 2002 · External reference
Carvedilol and bisoprolol as initial therapy for adult hypertension without compelling indications
10.1038/s41440-018-0174-6 · 2019 · External reference
Effects of carvedilol on blood pressure in patients with mild to moderate hypertension. A dose response study
10.2165/00003495-198800366-00015 · 1988 · External reference
Low-dose alpha/beta blockade in the treatment of essential hypertension
10.1016/s0895-7061(00)01302-9 · 2001 · External reference
Doxazosin in combination with atenolol in essential hypertension: a double-blind placebo-controlled multicentre trial
10.1007/bf00315116 · 1990 · External reference
The addition of doxazosin to the treatment regimen of patients with hypertension not adequately controlled by beta-blockers
10.1016/0002-8703(91)90864-e · 1991 · External reference
Concomitant administration of terazosin and atenolol for the treatment of essential hypertension
10.1001/archinte.1988.00380030045010 · 1988 · External reference
Beta-blockers are not all the same: pharmacologic similarities and differences, potential combinations and clinical implications
10.1080/03007995.2024.2318058 · 2024 · External reference
Clinical pharmacology of doxazosin in patients with essential hypertension
10.1038/clpt.1987.54 · 1987 · External reference
Efficacy and safety of renal denervation for the management of arterial hypertension: a systematic review and meta-analysis of randomized, sham-controlled, catheter-based trials
10.1111/jch.13827 · 2020 · External reference
